Pneumology - Original Articles Open access

Utility of lung ultrasound in assessing severity of interstitial lung diseases: correlation with high-resolution computed tomography and spirometry findings

Authors

Published
21 September 2026
Issue
Early Access
Section
Pneumology - Original Articles

Abstract

Interstitial lung diseases (ILDs) constitute a diverse category of diffuse parenchymal lung disorders whose diagnosis and monitoring are challenging due to complex clinic-radiological profiles and the risks of serial high-resolution computed tomography (HRCT). Lung ultrasound (LUS) has potential to become an easily available, non-ionizing substitute, though its comparative performance against HRCT and spirometry in severity assessment has been inadequately studied. We conducted a cross-sectional study of 52 adult ILD outpatients enrolled over one year, excluding those with cardiac failure, pulmonary tuberculosis, neoplasia, pregnancy, or acute ILD exacerbation. Each patient underwent LUS using a linear probe to determine total B-line score, total positive chest areas with ≥5 B-lines, and pleural line abnormalities; HRCT was scored by the Warrick system, and spirometry measured forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). There was a substantial correlation (r=0.75, p<0.001) between the Total B-line score (mean 39.3±15.3) and the Warrick score (11.94±5.09) and the Warrick score and total positive chest area score (r=0.77, p<0.001). Notable unfavorable associations were observed between LUS B-line score and FVC (r=−0.75, p=0.00) and FEV1 (r=−0.73, p=0.00). LUS demonstrated sensitivity of 97.9% and diagnostic accuracy of 94.2% compared with HRCT, though specificity was moderate (60%). These findings indicate that LUS closely mirrors HRCT and spirometry in assessing ILD severity. Given its high sensitivity, safety profile, and accessibility, LUS may serve as a valuable adjunct for routine evaluation and follow-up of ILD patients, particularly where repeated HRCT is impractical. Further large-scale, prospective studies are required to validate standardized LUS scoring and establish its role in guiding ILD management.

Ethics Approval

The institutional ethical review board granted a waiver for ethical clearance for this study as no ethical issues were found (F.1/IEC/MAMC/70/5/2019/569).

References

  1. Devaraj A. Imaging: how to recognise idiopathic pulmonary fibrosis. Eur Respir Rev 2014;23:215-9. DOI: https://doi.org/10.1183/09059180.00001514
  2. Volpicelli G, Elbarbary M, Blaivas M, et al. International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 2012;38:577-91. DOI: https://doi.org/10.1007/s00134-012-2513-4
  3. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis—evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824. DOI: https://doi.org/10.1164/rccm.2009-040GL
  4. Mohammadi A, Oshnoei S, Ghasemi-Rad M. Comparison of a new, modified lung ultrasonography technique with high-resolution CT in the diagnosis of the alveolo-interstitial syndrome of systemic scleroderma. Med Ultrason 2014;16:27-31. DOI: https://doi.org/10.11152/mu.2014.2066.161.am1so2
  5. Çakir Edis E, Hatipoğlu ON, Pamuk ÖN, et al. Effectiveness of thoracic ultrasonography in the evaluation of the severity of pulmonary involvement in patients with systemic sclerosis. Arch Rheumatol 2016;31:364-70. DOI: https://doi.org/10.5606/ArchRheumatol.2016.5849
  6. Tardella M, Gutierrez M, Salaffi F, et al. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis. Medicine 2018;97:18. DOI: https://doi.org/10.1097/MD.0000000000010566
  7. Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755-9. DOI: https://doi.org/10.1148/radiology.176.3.2389033
  8. Picano E, Matucci-Cerinic M. Unnecessary radiation exposure from medical imaging in the rheumatology patient. Rheumatology 2011;50:1537-9. DOI: https://doi.org/10.1093/rheumatology/keq412
  9. Barskova T, Gargani L, Guiducci S, et al. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Ann Rheum Dis 2013;72:390-5. DOI: https://doi.org/10.1136/annrheumdis-2011-201072
  10. Cogliati C, Antivalle M, Torzillo D, et al. Standard and pocket-Size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patients. Rheumatology 2014;53:1497-503. DOI: https://doi.org/10.1093/rheumatology/keu033
  11. Vizioli L, Ciccarese F, Forti P, et al. Integrated use of lung ultrasound and chest x-ray in the detection of interstitial lung disease. Respiration 2017;93:15-22. DOI: https://doi.org/10.1159/000452225
  12. Asano M, Watanabe H, Sato K, et al. Validity of ultrasound lung comets for assessment of the severity of interstitial pneumonia. J Ultrasound Med 2018;37:1523-31. DOI: https://doi.org/10.1002/jum.14497
  13. Fessi R, Ourari B, ben Amar J, et al. High-resolution computed tomography fibrosis score and pulmonary function tests in interstitial lung disease: Is there any correlation? Eur Respir J Suppl 2018;52:PA2926. DOI: https://doi.org/10.1183/13993003.congress-2018.PA2926
  14. Man MA, Dantes E, Hancu BD, et al. Correlation between transthoracic lung ultrasound score and HRCT features in patients with interstitial lung diseases. J Clin Med 2019;8:1199. DOI: https://doi.org/10.3390/jcm8081199
  15. Picano E, Frassi F, Agricola E, et al. Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr 2006;19:356-63. DOI: https://doi.org/10.1016/j.echo.2005.05.019

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.